Effects of IFIH1 rs1990760 variants on systemic inflammation and outcome in critically ill COVID-19 patients in an observational translational study
관찰 중개 연구에서 중환자 COVID-19 환자의 전신 염증 및 결과에 대한 IFIH1 rs1990760 변이체의 효과
Research Article
[키워드] 95% CI
95% confidence interval
analyzed
Anti-inflammatory
anti-inflammatory phenotype
applied
benefit
Blood
cause
Cell
changes in
clinical trial
clinical trials
coding
Cohort
Concentration
Corticosteroid
corticosteroid treatment
Corticosteroids
COVID
COVID-19
COVID-19 patient
COVID-19 patients
Critically ill
death
determine
Dexamethasone
discharge
distribution
drug
Effect
ENCODE
experiment
expression
Factor
funding
Gene Expression
greater
hazard ratio
healthy volunteer
healthy volunteers
help
hospital
host response
Human
ICU
IFIH1
IL-6
IL6
immune
Immune cell
immune cells
immune system
Impact
in-silico
increase in
individual
Infection
Inflammation
Inflammatory response
intensive care
intensive care unit
Laboratory
less
lower expression
Lung injury
MDA5
mechanical ventilation
mediators
moderate to severe
modulate
mononuclear cell
mononuclear cells
Mortality
outcome
outcomes
Pathways
Patient
patients
patients with moderate
peripheral
Peripheral blood
Peripheral blood mononuclear cells
pharmacogenomics
physician
populations
pro-inflammatory mediators
prospectively studied
Protein
recognize
Red
reduce
regulate
respond
risk
RNA
serum
Serum IL-6
severe COVID-19
Spain
steroid
Steroids
supported
survived
systemic inflammation
team
the patient
translational
treat
treated
Treatment
triggered
variant
variants
Variation
Viral
viral infections
virus
viruses
were measured
[DOI] 10.7554/eLife.73012 PMC 바로가기 [Article Type] Research Article
[DOI] 10.7554/eLife.73012 PMC 바로가기 [Article Type] Research Article